These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Assessment of the health status in the Massa Lombarda cohort: a preliminary description of the program evaluating cardio-cerebro-vascular disease risk factors and quality of life in an elderly population. Nascetti S; Linarello S; Scurti M; Grandi E; Gaddoni M; Noera G; Gaddi A Arch Gerontol Geriatr Suppl; 2004; (9):309-14. PubMed ID: 15207428 [TBL] [Abstract][Full Text] [Related]
6. Application of ambulatory blood pressure monitoring in essential hypertension with target-organ damage. Chen H; Wu X; Yang L; Bai Y Chin Med Sci J; 2000 Sep; 15(3):186. PubMed ID: 12903782 [No Abstract] [Full Text] [Related]
7. Heart disease. N C Med J; 1989 Jan; 50(1):27-30. PubMed ID: 2915709 [No Abstract] [Full Text] [Related]
10. Hypertension and heart disease: how much is enough? Kopes-Kerr CP Am Fam Physician; 1996 May; 53(7):2272, 2275. PubMed ID: 8638497 [No Abstract] [Full Text] [Related]
11. [Polymorphism of apolipoprotein E and its association with cardiovascular disease]. Gamboa R; Hernández-Pacheco G; Hesiquio R; Zúñiga J; Granados J; Vargas-Alarcón G Arch Inst Cardiol Mex; 1999; 69(4):375-82. PubMed ID: 10553197 [No Abstract] [Full Text] [Related]
12. [Importance of the cardiac factor in the manifestation of initial cerebral circulatory insufficiency in pilots]. Parmenov-Trifilov BI; Starikov LI; Kudin VP; Skrylev EP Voen Med Zh; 1980 Jul; (7):53-6. PubMed ID: 7405059 [No Abstract] [Full Text] [Related]
14. [Genetic polymorphism of the E apolipoprotein in school age children: comparison with levels of plasma lipids and apolipoproteins]. Callas N; Poveda E; Baracaldo C; Hernández P; Castillo C; Guerra M Biomedica; 2007 Dec; 27(4):526-36. PubMed ID: 18320120 [TBL] [Abstract][Full Text] [Related]
15. White matter lesion severity in male and female patients with Fabry disease. Fellgiebel A; Müller MJ; Mazanek M; Baron K; Beck M; Stoeter P Neurology; 2005 Aug; 65(4):600-2. PubMed ID: 16116124 [TBL] [Abstract][Full Text] [Related]
16. [The central role of apolipoprotein E in the nervous system]. Sun MZ; Qi ZH Sheng Li Ke Xue Jin Zhan; 1999 Jan; 30(1):57-9. PubMed ID: 12532852 [No Abstract] [Full Text] [Related]
17. Nonsteroidal anti-inflammatory drugs in patients with cardio- or cerebrovascular disorders. Stöllberger C; Finsterer J Z Kardiol; 2003 Sep; 92(9):721-9. PubMed ID: 14508588 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E phylogeny and evolution. Kasap M; Sazci A; Akpinar G; Ergul E Cell Biochem Funct; 2008; 26(1):43-50. PubMed ID: 17265535 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E and cognitive performance. Raber J; Wong D; Yu GQ; Buttini M; Mahley RW; Pitas RE; Mucke L Nature; 2000 Mar; 404(6776):352-4. PubMed ID: 10746713 [No Abstract] [Full Text] [Related]
20. Susceptibility to herpes simplex labialis conferred by the gene encoding apolipoprotein E. Itzhaki R; Wozniak M J Infect Dis; 2008 Aug; 198(4):624-5; author reply 625-6. PubMed ID: 18652551 [No Abstract] [Full Text] [Related] [Next] [New Search]